Abstract
Sialyl-Tn antigen (SAα2-6 GalNAcα-Ser/Thr) is expressed as a cancer-associated antigen on the surface of cancer cells and its expression correlates with a poor prognosis in patients with colorectal and other adenocarcinomas. To understand the enzymatic basis of sialyl-Tn (STn) antigen expression, we used two clonal cell lines, LSB and LSC, derived from LS174T human colonic cancer cells. LSC cells express only the truncated carbohydrate antigen Tn (GalNAcα-Ser/Thr) and sialyl-Tn on their mucin molecules, whereas LSB cells express elongated oligosaccharide chains. Both cell lines demonstrated similar activities of glycosyltransferases involved in the biosynthesis of elongated and terminal structures of complex O-glycans. However, LSC cells were unable to synthesize core 1 (Galβ1-3GalNAc-) because the ubiquitous enzyme activity of UDP-Gal:GalNAc-R β3-Gal-transferase (core 1 β3-Gal-transferase) was lacking. Core 1 β3-Gal-transferase could not be reactivated in LSC cells by treatment with sodium butyrate or by in vivo growth of LSC cells in nude mice. In contrast, LSB cells were able to synthesize and process core 1 and core 2 (GlcNAcβ1-6 (Galβ1-3) GalNAc-). LSC cells represent the first example of a non-hematopoietic cell line which lacks core 1 β3-Gal-transferase activity. The lack of core 1 β3-Gal-transferase in LSC cells explains why they are incapable of forming the common mucin O-glycan core structures and are committed to synthesizing the short Tn and STn oligosaccharides. These findings suggest that the activity of core 1 β3-Gal-transferase is an important determinant of the STn phenotype of colon cancer cells.
Similar content being viewed by others
References
Podolsky DK (1985) J Biol Chem 260: 15510–15.
Podolsky DK (1985) J Biol Chem 260: 8262–71.
Brockhausen I, Matta KL, Orr J, Schachter H (1985) Biochemistry 24: 1866–74.
Yang J, Byrd JC, Siddiki B, Chung YS, Okuno M, Sowa M, Kim YS, Matta KL, Brockhausen I (1994) Glycobiology 4: 873–84.
Dahiya R, Itzkowitz SH, Byrd JC, Kim YS (1992) Cancer 70: 1467–76.
Springer GF (1984) Science 224: 1198–1206.
Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, Kim YS (1989) Cancer Res 49: 197–204.
Orntoft TF, Harving N, Langkilde NC (1990) Int J Cancer 45: 666–72.
Yonezawa S, Tachikawa T, Shin S, Sato E (1992) Am J Clin Pathol 98: 167–74.
Itzkowitz SH, Bloom EJ, Lau TS, Kim YS (1992) Gut 33: 518–23.
Itzkowitz SH, Young E, Dubois D, Harpaz N, Bodian C, Chen A, Sachar DB (1996) Gastroenterology 110: 694–704.
Itzkowitz SH, Kjeldsen T, Friera A, Hakomori S, Yang U, Kim YS (1991) Gastroenterology 100: 1691–700.
Inoue M, Ogawa H, Tanizawa O, Kobayashi Y, Tsujimoto M, Tsujimura T (1991) Virchows Arch A Pathol Anat 418: 157–62.
Miles DW, Happerfield LC, Smith P, Gillibrand R, Bobrow LG, Gregory WM, Rubens RD (1994) Br J Cancer 70: 1272–5.
Kobayashi H, Terao T, Kawashima Y (1992) J Clin Oncol 10: 95–101.
Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori S, Kim YS (1990) Cancer 66: 1960–6.
Werther JL, Tatematsu M, Klein R, Kurihara K, Kumagai K, Llorens P, Neto JG, Bodian C, Pertsemlidis D, Yamachika T, Kitou T, Itzkowitz SH (1996) Int J Cancer (Pred Oncol) 69: 193–9.
Ogata S, Ho I, Chen A, Dubois D, Maklansky J, Singhal A, Hakomori S, Itzkowitz SH (1995) Cancer Res 55: 1869–74.
Jass JR, Allison LM, Edgar S (1994) Pathology 26: 418–22.
Jass JR, Allison LJ, Edgar S (1995) J Pathol 176: 143–9.
Devine PL, Clark BA, Birrell GW, Layton GT, Ward BG, Alewood PF, McKenzie IFC (1991) Cancer Res 51: 5826–36.
Brockhausen I (1993) Crit Rev Clin Lab Sci 301: 65–151.
Brockhausen I (1995) In New Comprehensive Biochemistry 29a (Montreuil J, Vliegenthart JFG, Schachter H, eds) pp 201–59 Elsevier.
Brockhausen I, Kuhns W (1997) Glycoproteins and Human Disease Austin, TX: R.G. Landes Co.
Ogata S, Chen A, Itzkowitz SH (1994) Cancer Res 54: 4036–44.
Brockhausen I, Romero P, Herscovics A (1991) Cancer Res 51: 3136–42.
Kuhns W, Jain R, Matta KL, Paulsen H, Baker MA, Geyer R, Brockhausen I (1995) Glycobiology 5: 689–97.
Brockhausen I, Toki D, Brockhausen J, Meldal M, Peters S, Bielfeld T, Paulsen H, Hagen F, Tabak L (1995) Glycoconjugate J 13: 849–56.
Kuhns W, Rutz V, Paulsen H, Matta KL, Baker MA, Barner M, Granovsky M, Brockhausen I (1993) Glycoconjugate J 10: 381–94.
Vavasseur F, Yang J, Dole K, Paulsen H, Brockhausen I (1995) Glycobiology 5: 351–7.
Pollex-Krüger A, Meyer B, Stuike-Prill R, Sinnwell V, Matta KL, Brockhausen I (1993) Glycoconjugate J 10: 365–80.
Vavassseur F, Dole K, Yang J, Matta KL, Myerscough N, Corfield A, Paraskewa C, Brockhausen I (1994) Eur J Biochem 222: 415–24.
Bresalier RS, Byrd JC, Brodt P, Itzkowitz SH (1995) Gastroenterol 108: A452.
Kuan SF, Byrd JC, Basbaum C, Kim YS (1989) J Biol Chem 264: 19271–7.
Bresalier RS, Niv Y, Byrd JC, Duh QY, Toribara NW, Rockwell RW, Dahiya R, Kim YS (1991) J Clin Invest 87: 1037–45.
Kojima N, Handa K, Newman W, Hakomori SI (1992) Biochem Biophys Res Comm 182: 1288–95.
Byrd JC, Dahiya R, Huang J, Kim YS (1995) Eur J Cancer 31A: 1498–505.
Piller V, Piller F, Fukuda M (1990) J Biol Chem 265: 9264–71.
Cartron JP, Andreu G, Cartron J, Bird GWG, Salmon C, Gerbal A (1978) Eur J Biochem 92: 111–19.
Thurnher M, Clausen H, Fierz W, Lanzavecchia A, Berger EG (1992) Eur J Immunol 22: 1835–42.
Berger EG, Dinter A, Thurnher M (1994) Trends in Glycoscience and Glycotechnology 6: 51–63
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brockhausen, I., Yang, J., Dickinson, N. et al. Enzymatic basis for sialyl-Tn expression in human colon cancer cells. Glycoconj J 15, 595–603 (1998). https://doi.org/10.1023/A:1006967910803
Issue Date:
DOI: https://doi.org/10.1023/A:1006967910803